Senvelgo Oral Solution for Cats

SENVELGO (velagliflozin oral solution) is indicated to improve glycemic control in otherwise healthy cats with diabetes mellitus not previously treated with insulin.

• Reduces persistent hyperglycemia, leading to effective glycemic control in as soon as 1 week
• Minimal risk of clinical hypoglycemic events
• Precise dosing tailored to the cat’s weight 
• Significantly reduces the need for blood glucose monitoring
• Well accepted by most cats
• Easy storage—no refrigeration needed before or after opening

Possible Side Effects

Contraindications: Do not use SENVELGO (velagliflozin oral solution) in cats with diabetes mellitus who have previously been treated with insulin, who are receiving insulin, or in cats with insulin-dependent diabetes mellitus. The use of SENVELGO in cats with insulin-dependent diabetes mellitus, or the withdrawal of insulin and initiation of SENVELGO, is associated with an increased risk of diabetic ketoacidosis or euglycemic diabetic ketoacidosis and death.

 SENVELGO is indicated to improve glycemic control in otherwise healthy cats with diabetes mellitus not previously treated with insulin. Before using this product, it is important to read the entire product insert, including the boxed warning. 

Cats treated with SENVELGO may be at an increased risk of diabetic ketoacidosis or euglycemic diabetic ketoacidosis, both of which may result in death. Development of these conditions should be treated promptly, including insulin administration and discontinuation of SENVELGO. 

Do not use SENVELGO in cats with diabetes mellitus who have previously been treated with insulin, who are receiving insulin, or in cats with insulin-dependent diabetes mellitus. The use of SENVELGO in cats with insulin-dependent diabetes mellitus, or the withdrawal of insulin and initiation of SENVELGO, is associated with an increased risk of diabetic ketoacidosis or euglycemic diabetic ketoacidosis and death. 

Directions for Use

Use as directed by your veterinarian. 

SENVELGO^® (velagliflozin oral solution) should be administered using the dosing syringe provided in the package. The dosing syringe fits onto the bottle and has a body weight scale with increments per pound of body weight. The dose should be rounded down to the nearest pound. After administration, close the bottle tightly with the cap. If needed, the syringe can be cleaned with a clean, dry cloth.

Warnings

Not for use in humans. Keep out of reach of children.

Wash hands after use. This product may cause mild eye irritation. Avoid contact with eyes. If the product accidentally gets into the eyes, rinse eyes immediately with plenty of water; if wearing contact lenses, rinse the eyes first then remove contact lens(es) and continue to rinse for 5-10 minutes. If eye irritation continues or accidental ingestion occurs, seek medical advice and provide this product information to the physician. Exposure to product may induce local or systemic allergic reaction in sensitized individuals. Oral exposure to velagliflozin may cause transient effects such as increased renal glucose excretion, increased urine volume, and hypoglycemia.

Prescription items are NON-RETURNABLE and NON-REFUNDABLE.